To revascularize or not before transcatheter aortic valve implantation?

Sergio Perez, Torin P. Thielhelm, Mauricio G. Cohen

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


Concomitant coronary artery disease (CAD) and aortic stenosis occur in approximately 60-75% of patients referred for surgical or transcatheter aortic valve replacement (TAVR). Current guidelines support simultaneous surgical aortic valve replacement and bypass surgery with a class IIa recommendation, based on observational, non-randomized data. With the inception of TAVR, this strategy has been challenged, as observational studies have not shown significant outcome differences in patients with and without CAD treated with TAVR. Performing percutaneous coronary intervention (PCI) in patients with aortic stenosis is safe, but the indication and timing remain controversial. Complete revascularization before TAVR with low residual Syntax score (<8) may be considered in selected cases with extensive, proximal, and severe CAD to improve outcomes. PCI before TAVR may require less contrast and reduce the risk of acute kidney injury, but uninterrupted dual antiplatelet therapy may increase the risk of bleeding during TAVR. Combined PCI and TAVR can be considered for unstable patients with simple lesions or ostial lesions, with risk of coronary occlusion after deployment of the transcatheter heart valve. PCI after TAVR may be considered in patients who remain symptomatic with significant residual ischemia despite optimal medical therapy. In the near future, it is expected that randomized clinical trials will further clarify the indications and role of revascularization in patients undergoing TAVR. In this article we provide an extensive review on the management of CAD in TAVR candidates, including additional considerations on technical aspects, device selection, and adjunctive pharmacological therapies.

Original languageEnglish (US)
Pages (from-to)S3578-S3587
JournalJournal of Thoracic Disease
StatePublished - Nov 1 2018


  • Aortic stenosis (AS)
  • Coronary artery disease (CAD)
  • Percutaneous coronary intervention (PCI)
  • Revascularization
  • Transcatheter aortic valve replacement (TAVR)

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'To revascularize or not before transcatheter aortic valve implantation?'. Together they form a unique fingerprint.

Cite this